New Findings in Structural Heart Disease Care

November 23, 2021

Torrey Loper

Share on social:

Follow egnite on social:

New appointments add structural heart, cardiothoracic surgery, and real-world outcomes expertise to advance egnite’s cardiovascular intelligence platform ALISO VIEJO, Calif. — June 18, 2026 — egnite, Inc., a healthcare AI company focused on helping clinicians identify and manage patients with untreated heart disease, today announced the expansion of its Medical Advisory Board (MAB). Joining the MAB are three distinguished cardiovascular specialists: Vijay Iyer, MD, PhD, FACC, Chief

Press

egnite Launches New Lp(a) Identification Capability to Accelerate Clinical Trial Enrollment

egnite’s CardioCare Research Suite now identifies Lp(a) patients at health system scale, helping clinical trial teams to successfully find patients with elevated Lp(a) who were previously undetected due to current limitations in technology and workflow.

Press

egnite, Inc. Receives U.S. Patent for NLP-Based Algorithm That Classifies Mitral Regurgitation Mechanism from Echocardiographic Reports

egnite, Inc., a leading digital health company specializing in cardiovascular care, today announced the addition of two distinguished physicians, Vinod H. Thourani, MD and Nicholas Amoroso, MD to its Medical Advisory Board. Their wealth of expertise in cardiovascular care and dedication to innovation will significantly contribute to egnite’s mission to improve cardiovascular patient care nationwide.

New Findings in Structural Heart Disease Care

Related Articles

egnite Expands Medical Advisory Board with Three Nationally Recognized Cardiovascular Specialists

egnite Launches New Lp(a) Identification Capability to Accelerate Clinical Trial Enrollment

egnite, Inc. Receives U.S. Patent for NLP-Based Algorithm That Classifies Mitral Regurgitation Mechanism from Echocardiographic Reports